Exploring 52 Asco 2023 Plenary Session
Exploring 52 Asco 2023 Plenary Session reveals several interesting facts.
- Dr. Monty Pal of City of Hope analyzes the results of the RASolute-302 trial comparing daraxonrasib versus chemotherapy in ...
- Dr Richard Bambury presents an all-encompassing summary that showcases his insights from
- https://support.doctorpodcasting.com/media/k2/items/cache/a1495a8aa7b5af032a3a0ddf4b0d0134_Generic.jpg) The
- ASCO
- Dr. Eric J. Small, MD, FASCO, President, American Society of Clinical Oncology (
In-Depth Information on 52 Asco 2023 Plenary Session
Theodore Roosevelt is famously quoted saying: "It is hard to fail, but it is worse never to have tried to succeed." This is what An interview with Dr. Alex Herrera from City of Hope on the SWOG S1826 study for the For more information, visit https://conferences. Melissa Johnson, MD, Sarah Cannon Research Institute, Nashville, TN, talks through the abstracts presented during the
Vinay Prasad, MD MPH HemeOnc Doctor & Associate Professor of Epi/ Biostats Host of
Stay tuned for more updates related to 52 Asco 2023 Plenary Session.
